These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 30141833)

  • 1. Medical costs associated with chronic kidney disease progression in an Asian population with type 2 diabetes mellitus.
    Low S; Lim SC; Zhang X; Wang J; Yeo SJD; Yeoh LY; Liu YL; Subramaniam T; Sum CF
    Nephrology (Carlton); 2019 May; 24(5):534-541. PubMed ID: 30141833
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The economic burden of progressive chronic kidney disease among patients with type 2 diabetes.
    Vupputuri S; Kimes TM; Calloway MO; Christian JB; Bruhn D; Martin AA; Nichols GA
    J Diabetes Complications; 2014; 28(1):10-6. PubMed ID: 24211091
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Annual health care resource utilization and cost among type 2 diabetes patients with newly recognized chronic kidney disease within a large U.S. administrative claims database.
    Folkerts K; Petruski-Ivleva N; Kelly A; Fried L; Blankenburg M; Gay A; Kovesdy CP
    J Manag Care Spec Pharm; 2020 Dec; 26(12):1506-1516. PubMed ID: 33251992
    [No Abstract]   [Full Text] [Related]  

  • 4. Medical Costs Associated with Severity of Chronic Kidney Disease in Type 2 Diabetes Mellitus in Singapore.
    Lim GJ; Liu YL; Low S; Ang K; Tavintharan S; Sum CF; Lim SC
    Ann Acad Med Singap; 2020 Oct; 49(10):731-741. PubMed ID: 33283836
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diabetes mellitus as a cause or comorbidity of chronic kidney disease and its outcomes: the Gonryo study.
    Iwai T; Miyazaki M; Yamada G; Nakayama M; Yamamoto T; Satoh M; Sato H; Ito S
    Clin Exp Nephrol; 2018 Apr; 22(2):328-336. PubMed ID: 28752289
    [TBL] [Abstract][Full Text] [Related]  

  • 6. What is the impact of chronic kidney disease stage and cardiovascular disease on the annual cost of hospital care in moderate-to-severe kidney disease?
    Kent S; Schlackow I; Lozano-Kühne J; Reith C; Emberson J; Haynes R; Gray A; Cass A; Baigent C; Landray MJ; Herrington W; Mihaylova B;
    BMC Nephrol; 2015 Apr; 16():65. PubMed ID: 25924679
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cost-utility analysis of the National Health Screening Program for chronic kidney disease in Korea.
    Go DS; Kim SH; Park J; Ryu DR; Lee HJ; Jo MW
    Nephrology (Carlton); 2019 Jan; 24(1):56-64. PubMed ID: 29206319
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The association between the severity of chronic kidney disease and medical costs among patients with type 2 diabetes.
    Lage MJ; Boye KS; Bae JP; Wu J; Mody R; Botros FT
    J Med Econ; 2019 May; 22(5):447-454. PubMed ID: 30736708
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Medical care expenditures associated with chronic kidney disease in adults with diabetes: United States 2011.
    Ozieh MN; Dismuke CE; Lynch CP; Egede LE
    Diabetes Res Clin Pract; 2015 Jul; 109(1):185-90. PubMed ID: 25935258
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Body mass index has no effect on rate of progression of chronic kidney disease in subjects with type 2 diabetes mellitus.
    Mohsen A; Brown R; Hoefield R; Kalra PA; O'Donoghue D; Middleton R; New D
    J Nephrol; 2012; 25(3):384-93. PubMed ID: 22241634
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence and risk factors for chronic kidney disease in primary health care in the southern region of New Zealand.
    Lloyd H; Li G; Tomlin A; Tilyard MW; Walker R; Schollum J
    Nephrology (Carlton); 2019 Mar; 24(3):308-315. PubMed ID: 29717528
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of haemoglobin A1c trajectories on chronic kidney disease progression in type 2 diabetes.
    Low S; Zhang X; Wang J; Yeoh LY; Liu YL; Ang SF; Subramaniam T; Sum CF; Lim SC
    Nephrology (Carlton); 2019 Oct; 24(10):1026-1032. PubMed ID: 30565819
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Major adverse cardiovascular events in people with chronic kidney disease in relation to disease severity and diabetes status.
    Currie CJ; Berni ER; Berni TR; Jenkins-Jones S; Sinsakul M; Jermutus L; Ambery P; Jain M
    PLoS One; 2019; 14(8):e0221044. PubMed ID: 31461449
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Health Care Costs by Type of Expenditure across eGFR Stages among Patients with and without Diabetes, Cardiovascular Disease, and Heart Failure.
    Nichols GA; Ustyugova A; Déruaz-Luyet A; O'Keeffe-Rosetti M; Brodovicz KG
    J Am Soc Nephrol; 2020 Jul; 31(7):1594-1601. PubMed ID: 32487562
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development and validation of a predictive model for Chronic Kidney Disease progression in Type 2 Diabetes Mellitus based on a 13-year study in Singapore.
    Low S; Lim SC; Zhang X; Zhou S; Yeoh LY; Liu YL; Tavintharan S; Sum CF
    Diabetes Res Clin Pract; 2017 Jan; 123():49-54. PubMed ID: 27923172
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Descriptive study of the economic burden among patients with type 2 diabetes mellitus, chronic kidney disease, and chronic kidney disease and type 2 diabetes mellitus in a large US commercially insured population.
    Chung H; Crowe CL; Kong SX; Singh R; Farej R; Elliott J; Williamson T; Willey VJ
    J Manag Care Spec Pharm; 2023 Jan; 29(1):80-89. PubMed ID: 36580126
    [No Abstract]   [Full Text] [Related]  

  • 17. Risk Prediction for Early CKD in Type 2 Diabetes.
    Dunkler D; Gao P; Lee SF; Heinze G; Clase CM; Tobe S; Teo KK; Gerstein H; Mann JF; Oberbauer R;
    Clin J Am Soc Nephrol; 2015 Aug; 10(8):1371-9. PubMed ID: 26175542
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum uric acid to creatinine ratio: A predictor of incident chronic kidney disease in type 2 diabetes mellitus patients with preserved kidney function.
    Gu L; Huang L; Wu H; Lou Q; Bian R
    Diab Vasc Dis Res; 2017 May; 14(3):221-225. PubMed ID: 28183204
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Direct all-cause health care costs associated with chronic kidney disease in patients with diabetes and hypertension: a managed care perspective.
    Laliberté F; Bookhart BK; Vekeman F; Corral M; Duh MS; Bailey RA; Piech CT; Lefebvre P
    J Manag Care Pharm; 2009 May; 15(4):312-22. PubMed ID: 19422271
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Direct medical cost associated with diabetic retinopathy severity in type 2 diabetes in Singapore.
    Zhang X; Low S; Kumari N; Wang J; Ang K; Yeo D; Yip CC; Tavintharan S; Sum CF; Lim SC
    PLoS One; 2017; 12(7):e0180949. PubMed ID: 28700742
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.